S. Fukudo, M. Hongo, H. Kaneko
Jun 1, 2011
Citations
4
Influential Citations
79
Citations
Quality indicators
Journal
Neurogastroenterology & Motility
Abstract
Background Lubiprostone is a prostone analog with a novel mechanism of action involving type‐2 chloride channel activation. The aim of this work was to perform a dose‐finding study for lubiprostone for the treatment of constipation with or without irritable bowel syndrome (IBS) in Japan.